STOCK TITAN

3,736 LXEO Shares Proposed for Sale via Fidelity (LXEO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LXEO reported a proposed sale of 3,736 common shares via Fidelity Brokerage Services following restricted stock vesting on 02/17/2026. The filing lists a dollar figure of $23,896.58 associated with the securities and notes a prior sale of 549 shares on 11/18/2025 by Jenny R. Robertson.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records a proposed resale after restricted stock vesting, with historical recent sales noted.

The filing lists 3,736 common shares to be sold through Fidelity Brokerage Services LLC following restricted stock vesting on 02/17/2026. It also records a prior sale of 549 shares on 11/18/2025.

Timing and final execution details are not included in the excerpt; cash‑flow treatment and proceeds recipient beyond the broker routing are not specified in the provided text.

Scheduled insider sale stems from compensation vesting rather than open‑market planning.

The shares listed are tied to restricted stock vesting as compensation on 02/17/2026, indicating this is a routine conversion of compensation into transferable shares rather than an extraordinary disposition.

Subsequent filings may disclose execution details and whether the sales follow any pre‑arranged plan; the excerpt shows a recent related sale of 549 shares on 11/18/2025.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

LXEO Latest News

LXEO Latest SEC Filings

LXEO Stock Data

459.09M
67.58M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK